The tool, designed by the researchers at University of Sheffield in the UK, could help doctors make more informed prescriptions and reduce the number of patients with viral infections being prescribed antibiotics.
The device could enable patients with flu-like symptoms to give a small blood sample and be promptly told whether they have a bacterial or non-bacterial infection and be treated accordingly.
The diagnostic tool uses genetically engineered bacteria to detect the presence of a bacterial infection in a patient's blood sample.
This protein is produced in high levels by cells of the immune system in response to bacterial infections.
The protein's function is to bind to small molecules which bacteria use to access iron in order to grow.
Researchers are developing the device so that genetically modified bacteria mixes with a patient's blood sample and turn florescent when there are low levels of the lipocalin protein - indicating a viral not bacterial infection.
"The main aim behind this project is to create more informed prescriptions to address the ever increasing resistance against antibiotics that we face today," said Saylee Jangam, a student from the University of Sheffield.
"What is even more interesting is that we are using genetically engineered bacteria to detect the presence of bacterial infections in blood - that is right - using bacteria to detect bacteria," she added.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
